Release

Relieve party to a trade of any previously made obligation concerning that trade, hence allowing the would-be transactor to show the inquiry/order to a new broker.

Release

Written statement by a creditor to the effect that a debtor has either paid off the debt or the debt is otherwise discharged. A creditor may release a lien if the loan has been paid or if other collateral has been offered. Most mortgages contain release clauses indicating under what circumstances the borrower obtains release from the mortgage lien.

release

See release of lien.

Mentioned in

References in periodicals archive

To overcome time lag following administration before the drug reaches steady-state concentration in the body, some sustained release products are formulated with an instant release in the outer coating.

Excipients in drug delivery: trends in excipient selection for sustained release formulations

AP Pharma, a specialty pharmaceutical company, has started a programme to expand its range of sustained release products, including a new programme targeting the relief of post-surgical pain, it was reported yesterday.

AP Pharma starts programme to expand range of sustained release products

Medidur uses the same injectable, sustained release micro-insert as pSivida's lead licensed product, Iluvien for the treatment of DME.

PSivida Reports Commencement of Iluvien Sales in Portugal

The company said that the '703 patent includes claims directed to methods of improving lower extremity function and walking and increasing walking speed in patients with multiple sclerosis (MS) by administering less than 15 mg of sustained release 4-aminopyridine (dalfampridine) twice daily.

Acorda Therapeutics Inc receives additional US Patent for AMPYRA covering range of dosage strengths

The "Global Sustained Release Coatings Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Global Sustained Release Coatings Market Analysis & Forecast (2016-2027): The Market is Witnessing Increasing Bioavailability

UroGen has developed RTGel reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs.

UroGen Pharma to Report Second Quarter 2019 Financial Results on Friday, August 9, 2019

Amongst diverse excipients available, sustained release excipients have gained ample adoption to curb the risk of insufficient treatment more emphatically in drugs which have multiple administration in 24 hours.

Sustained Release Excipients Market: Ample Adoption in Pediatric and Geriatric Drugs to Unwind Tangi

The company has developed RTGel reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs.

UroGen Pharma Inks Early Stage Feasibility Agreement with Janssen

The research study is titled " Global Sustained Release Excipients Market - Growth Overview and Predictions on Size, Share and Trend Through 2028 " which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview.

Global Sustained Release Excipients Market - Growth Overview and Predictions on Size, Share and Tren

The active drug is encapsulated within these tiny biodegradable microspheres, which provides sustained release delivery of dexamethasone.

Purdue Pharma Enters into Exclusive Option to Acquire SpineThera and Its Non-Opioid Product in Development